A fusion of two existing drugs alleviates autism-like features in a mouse model of the condition, according to a new study1.

The fusion drug, called NitroSynapsin, boosts social interest and alleviates some repetitive behaviors in mice missing one copy of the autism candidate gene MEF2C.

View Full Article

You need to login or register to bookmark/favorite this content.